S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: NYSE
DilutionScan read 26 of Kairos Pharma, LTD.'s SEC filings and found 7 warrant series, 1 ATM program, 1 equity line, 1 shelf registration, 2 S-1 registrations and 2 completed offerings on file for KAPA. The latest dilution event on file is ATM sales on Aug 12, 2026. Analysis updated Nov 3, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 + active equity line · latest dilution event 83 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 12, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Issued 2025
Proposed maximum
Shares registered
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2026
Total capacity
Sold to date
Issued 2024
Commitment
Sold to date
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z